![](/img/cover-not-exists.png)
Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues
Zoutendijk, R., Sonneveld, M. J., Reijnders, J. G. P., van Vuuren, A. J., Biesta, P., Hansen, B. E., Boonstra, A., Janssen, H. L. A.Volume:
20
Language:
english
Journal:
Journal of Viral Hepatitis
DOI:
10.1111/jvh.12033
Date:
May, 2013
File:
PDF, 120 KB
english, 2013